Cellebrite DI Statistics
Total Valuation
Cellebrite DI has a market cap or net worth of $5.05 billion. The enterprise value is $4.67 billion.
Important Dates
The next confirmed earnings date is Thursday, February 13, 2025, before market open.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Cellebrite DI has 218.19 million shares outstanding. The number of shares has increased by 6.38% in one year.
| Current Share Class | 218.19M |
| Shares Outstanding | 218.19M |
| Shares Change (YoY) | +6.38% |
| Shares Change (QoQ) | +4.90% |
| Owned by Insiders (%) | 2.98% |
| Owned by Institutions (%) | 37.42% |
| Float | 91.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 60.50 |
| PS Ratio | 11.81 |
| Forward PS | 11.12 |
| PB Ratio | 15.94 |
| P/TBV Ratio | 19.64 |
| P/FCF Ratio | 49.55 |
| P/OCF Ratio | 46.10 |
| PEG Ratio | 2.35 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 69.55, with an EV/FCF ratio of 45.63.
| EV / Earnings | n/a |
| EV / Sales | 12.13 |
| EV / EBITDA | 69.55 |
| EV / EBIT | 83.16 |
| EV / FCF | 45.63 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.84 |
| Quick Ratio | 1.70 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.17 |
| Debt / FCF | 0.12 |
| Interest Coverage | 0.22 |
Financial Efficiency
Return on equity (ROE) is -188.50% and return on invested capital (ROIC) is 19.48%.
| Return on Equity (ROE) | -188.50% |
| Return on Assets (ROA) | 6.35% |
| Return on Capital (ROIC) | 19.48% |
| Revenue Per Employee | $382,110 |
| Profits Per Employee | -$314,408 |
| Employee Count | 1,008 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 5.72 |
Taxes
In the past 12 months, Cellebrite DI has paid $8.70 million in taxes.
| Income Tax | 8.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +173.03% in the last 52 weeks. The beta is 1.46, so Cellebrite DI's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | +173.03% |
| 50-Day Moving Average | 20.63 |
| 200-Day Moving Average | 15.60 |
| Relative Strength Index (RSI) | 67.96 |
| Average Volume (20 Days) | 1,179,521 |
Short Selling Information
The latest short interest is 1.17 million, so 0.54% of the outstanding shares have been sold short.
| Short Interest | 1.17M |
| Short Previous Month | 1.03M |
| Short % of Shares Out | 0.54% |
| Short % of Float | 1.28% |
| Short Ratio (days to cover) | 1.11 |
Income Statement
In the last 12 months, Cellebrite DI had revenue of $385.17 million and -$316.92 million in losses. Loss per share was -$1.59.
| Revenue | 385.17M |
| Gross Profit | 325.28M |
| Operating Income | 56.18M |
| Pretax Income | -106.25M |
| Net Income | -316.92M |
| EBITDA | 67.17M |
| EBIT | 56.18M |
| Loss Per Share | -$1.59 |
Full Income StatementBalance Sheet
The company has $370.76 million in cash and $12.27 million in debt, giving a net cash position of $401.32 million or $1.84 per share.
| Cash & Cash Equivalents | 370.76M |
| Total Debt | 12.27M |
| Net Cash | 401.32M |
| Net Cash Per Share | $1.84 |
| Equity (Book Value) | 298.32M |
| Book Value Per Share | 1.43 |
| Working Capital | 228.53M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $110.03 million and capital expenditures -$7.65 million, giving a free cash flow of $102.38 million.
| Operating Cash Flow | 110.03M |
| Capital Expenditures | -7.65M |
| Free Cash Flow | 102.38M |
| FCF Per Share | $0.47 |
Full Cash Flow StatementMargins
Gross margin is 84.45%, with operating and profit margins of 14.59% and -82.28%.
| Gross Margin | 84.45% |
| Operating Margin | 14.59% |
| Pretax Margin | -80.02% |
| Profit Margin | -82.28% |
| EBITDA Margin | 17.44% |
| EBIT Margin | 14.59% |
| FCF Margin | 26.58% |
Dividends & Yields
Cellebrite DI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.38% |
| Shareholder Yield | -6.38% |
| Earnings Yield | -6.25% |
| FCF Yield | 2.02% |
Dividend DetailsAnalyst Forecast
The average price target for Cellebrite DI is $19.50, which is -15.73% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.50 |
| Price Target Difference | -15.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 16.55% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cellebrite DI has an Altman Z-Score of 5 and a Piotroski F-Score of 5.
| Altman Z-Score | 5 |
| Piotroski F-Score | 5 |